PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
VKTX vs. SPY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between VKTX and SPY is 0.28, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

VKTX vs. SPY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Viking Therapeutics, Inc. (VKTX) and SPDR S&P 500 ETF (SPY). The values are adjusted to include any dividend payments, if applicable.

-30.00%-20.00%-10.00%0.00%10.00%20.00%30.00%AugustSeptemberOctoberNovemberDecember2025
-28.16%
5.54%
VKTX
SPY

Key characteristics

Sharpe Ratio

VKTX:

0.86

SPY:

2.17

Sortino Ratio

VKTX:

2.83

SPY:

2.88

Omega Ratio

VKTX:

1.36

SPY:

1.40

Calmar Ratio

VKTX:

2.17

SPY:

3.26

Martin Ratio

VKTX:

3.79

SPY:

14.09

Ulcer Index

VKTX:

34.05%

SPY:

1.95%

Daily Std Dev

VKTX:

149.93%

SPY:

12.64%

Max Drawdown

VKTX:

-90.41%

SPY:

-55.19%

Current Drawdown

VKTX:

-55.92%

SPY:

-2.83%

Returns By Period

In the year-to-date period, VKTX achieves a 3.53% return, which is significantly higher than SPY's 0.44% return.


VKTX

YTD

3.53%

1M

-17.99%

6M

-23.07%

1Y

113.86%

5Y*

40.24%

10Y*

N/A

SPY

YTD

0.44%

1M

-2.83%

6M

6.59%

1Y

25.62%

5Y*

14.26%

10Y*

13.15%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

VKTX vs. SPY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VKTX
The Risk-Adjusted Performance Rank of VKTX is 8585
Overall Rank
The Sharpe Ratio Rank of VKTX is 7676
Sharpe Ratio Rank
The Sortino Ratio Rank of VKTX is 9191
Sortino Ratio Rank
The Omega Ratio Rank of VKTX is 8989
Omega Ratio Rank
The Calmar Ratio Rank of VKTX is 9191
Calmar Ratio Rank
The Martin Ratio Rank of VKTX is 7777
Martin Ratio Rank

SPY
The Risk-Adjusted Performance Rank of SPY is 8484
Overall Rank
The Sharpe Ratio Rank of SPY is 8484
Sharpe Ratio Rank
The Sortino Ratio Rank of SPY is 8282
Sortino Ratio Rank
The Omega Ratio Rank of SPY is 8383
Omega Ratio Rank
The Calmar Ratio Rank of SPY is 8383
Calmar Ratio Rank
The Martin Ratio Rank of SPY is 8585
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

VKTX vs. SPY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Viking Therapeutics, Inc. (VKTX) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for VKTX, currently valued at 0.86, compared to the broader market-4.00-2.000.002.000.862.17
The chart of Sortino ratio for VKTX, currently valued at 2.83, compared to the broader market-4.00-2.000.002.004.002.832.88
The chart of Omega ratio for VKTX, currently valued at 1.36, compared to the broader market0.501.001.502.001.361.40
The chart of Calmar ratio for VKTX, currently valued at 2.17, compared to the broader market0.002.004.006.002.173.26
The chart of Martin ratio for VKTX, currently valued at 3.79, compared to the broader market-10.000.0010.0020.003.7914.09
VKTX
SPY

The current VKTX Sharpe Ratio is 0.86, which is lower than the SPY Sharpe Ratio of 2.17. The chart below compares the historical Sharpe Ratios of VKTX and SPY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio1.002.003.004.005.00AugustSeptemberOctoberNovemberDecember2025
0.86
2.17
VKTX
SPY

Dividends

VKTX vs. SPY - Dividend Comparison

VKTX has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.20%.


TTM20242023202220212020201920182017201620152014
VKTX
Viking Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SPY
SPDR S&P 500 ETF
1.20%1.21%1.40%1.65%1.20%1.52%1.75%2.04%1.80%2.03%2.06%1.87%

Drawdowns

VKTX vs. SPY - Drawdown Comparison

The maximum VKTX drawdown since its inception was -90.41%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for VKTX and SPY. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-55.92%
-2.83%
VKTX
SPY

Volatility

VKTX vs. SPY - Volatility Comparison

Viking Therapeutics, Inc. (VKTX) has a higher volatility of 24.09% compared to SPDR S&P 500 ETF (SPY) at 4.49%. This indicates that VKTX's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%AugustSeptemberOctoberNovemberDecember2025
24.09%
4.49%
VKTX
SPY
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab